- Truvian Sciences, a San Diego, CA-based closed more than $105m in a Series C financing
- The round, which brought total funding to more than $150m to date, led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures
- Truvian is a healthcare company at the intersection of diagnostics and consumer technology
- Its automated benchtop system developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood
- The company also announced a roster of executive and board appointments
- Former Divisional VP of Automation and Informatics at Abbott, Jay Srinivasan, has joined the company as Chief Product Officer
